<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38212781</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>05</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1743-422X</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month><Day>11</Day></PubDate></JournalIssue><Title>Virology journal</Title><ISOAbbreviation>Virol J</ISOAbbreviation></Journal><ArticleTitle>The burden of persistent symptoms after COVID-19 (long COVID): a meta-analysis of controlled studies in children and adults.</ArticleTitle><Pagination><StartPage>16</StartPage><MedlinePgn>16</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">16</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12985-024-02284-3</ELocationID><Abstract><AbstractText Label="BACKGROUND">Previous meta-analyses estimating the prevalence of the post-COVID-19 condition (PCC) were confounded by the lack of negative control groups. This may result in an overestimation of the prevalence of those experiencing PCC, as these symptoms are non-specific and common in the general population. In this study, we aimed to compare the burden of persistent symptoms among COVID-19 survivors relative to COVID-19-negative controls.</AbstractText><AbstractText Label="METHODS">A systematic literature search was conducted using the following databases (PubMed, Web of Science, and Scopus) until July 2023 for comparative studies that examined the prevalence of persistent symptoms in COVID-19 survivors. Given that many of the symptoms among COVID-19 survivors overlap with post-hospitalization syndrome and post-intensive care syndrome, we included studies that compare the prevalence of persistent symptoms in hospitalized COVID-19 patients relative to non-COVID-19 hospitalized patients and in non-hospitalized COVID-19 patients relative to healthy controls that reported outcomes after at least 3 months since infection. The results of the meta-analysis were reported as odds ratios with a 95% confidence interval based on the random effects model.</AbstractText><AbstractText Label="RESULTS">Twenty articles were included in this study. Our analysis of symptomatology in non-hospitalized COVID-19 patients compared to negative controls revealed that the majority of symptoms examined were not related to COVID-19 infection and appeared equally prevalent in both cohorts. However, non-COVID-19 hospitalized patients had higher odds of occurrence of certain symptoms like anosmia, ageusia, fatigue, dyspnea, and brain fog (P&#x2009;&lt;&#x2009;0.05). Particularly, anosmia and ageusia showed substantially elevated odds relative to the negative control group at 11.27 and 9.76, respectively, P&#x2009;&lt;&#x2009;0.05. In contrast, analysis of hospitalized COVID-19 patients compared to those hospitalized for other indications did not demonstrate significantly higher odds for the tested symptoms.</AbstractText><AbstractText Label="CONCLUSIONS">The persistent symptoms in COVID-19 survivors may result from hospitalization for causes unrelated to COVID-19 and are commonly reported among the general population. Although certain symptoms exhibited higher odds in non-hospitalized COVID-19 patients relative to controls, these symptoms are common post-viral illnesses. Therefore, the persistent symptoms after COVID-19 may not be unique to SARS-CoV-2. Future studies including well-matched control groups when investigating persistent symptoms in COVID-19 survivors are warranted to draw a firm conclusion.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Azzam</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Immunology, Faculty of Pharmacy, Helwan University, Cairo, Egypt. ahmed.abdelkareem@pharm.helwan.edu.eg.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khaled</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Refaey</LastName><ForeName>Neveen</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Physical Therapy for Women's Health, Faculty of Physical Therapy, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mohsen</LastName><ForeName>Shorouk</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Public Health and Preventive Medicine Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El-Emam</LastName><ForeName>Ola Ali</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Clinical Pathology Department, Faculty of Medicine, Mansoura University, Mansoura, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dawood</LastName><ForeName>Nada</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Community Medicine Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Hebatalla A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department of Public Health and Community Medicine, Faculty of Medicine, Kafr-Elsheikh University, Kafr-Elsheikh, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Soliman</LastName><ForeName>Omar A</ForeName><Initials>OA</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacy, Alexandria, University Main Teaching Hospital, Alexandria, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Human Genetics Department, Medical Research Institute, Alexandria University, Alexandria, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mostafa</LastName><ForeName>Sana</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Oral Biology Department, Faculty of Dentistry, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ramadan</LastName><ForeName>Heba</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Pharmacy Department, Agamy Medical District, Ministry of Health and Population, Agamy, Alexandria, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mosa</LastName><ForeName>Maha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Otolaryngologist, Qeft Teaching Hospital, Qena, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elmowafy</LastName><ForeName>Amora Omar Ibrahim</ForeName><Initials>AOI</Initials><AffiliationInfo><Affiliation>Medical Surgical Nursing Department, Faculty of Nursing, Mansoura University, Mansoura, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rizk</LastName><ForeName>Shimaa Mohamed Abdou</ForeName><Initials>SMA</Initials><AffiliationInfo><Affiliation>Medical Surgical Nursing Department, Faculty of Nursing, Mansoura University, Mansoura, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zaki</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hussien</LastName><ForeName>Mostafa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Suez Canal University, Suez City, Ismailia Governorate, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Ameer</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Minia University, Minya, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ezzat</LastName><ForeName>Ahmad Ashraf</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Faculty of Pharmacy, Minia University, Minya, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan</LastName><ForeName>Fatma E</ForeName><Initials>FE</Initials><AffiliationInfo><Affiliation>Medical Physiology Department, Kasr Alainy, Faculty of Medicine, Cairo University, Giza, 11562, Egypt.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Physiology, General Medicine Practice Program, Batterjee Medical College, 21442, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D017418">Meta-Analysis</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virol J</MedlineTA><NlmUniqueID>101231645</NlmUniqueID><ISSNLinking>1743-422X</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000370" MajorTopicYN="N">Ageusia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086582" MajorTopicYN="N">Anosmia</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>1</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>15</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>1</Month><Day>11</Day><Hour>23</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>11</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38212781</ArticleId><ArticleId IdType="pmc">PMC10785462</ArticleId><ArticleId IdType="doi">10.1186/s12985-024-02284-3</ArticleId><ArticleId IdType="pii">10.1186/s12985-024-02284-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Post COVID-19 condition. https://www.who.int/teams/health-care-readiness/post-covid-19-condition. Accessed 24 Jul 2023.</Citation></Reference><Reference><Citation>Coronavirus disease (COVID-19): Post COVID-19 condition. https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(COVID-19)-post-COVID-19-condition?gclid=CjwKCAjwh8mlBhB_EiwAsztdBOP5fOn28uuTeR3KMKWnwH85acS0AGoSUqTwnFM_rMJT6a6kYbxENhoClRYQAvD_BwE. Accessed 24 Jul 2023.</Citation></Reference><Reference><Citation>Post COVID-19 condition (Long COVID). https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition. Accessed 24 Jul 2023.</Citation></Reference><Reference><Citation>Post-COVID Conditions: Information for Healthcare Providers. https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html. Accessed 24 Jul 2023.</Citation></Reference><Reference><Citation>Post-COVID-19 condition (long COVID): Canada.ca. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/symptoms/post-covid-19-condition.html. Accessed 24 Jul 2023.</Citation></Reference><Reference><Citation>Recommendations|COVID-19 rapid guideline: managing the long-term effects of COVID-19|Guidance|NICE.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1. Accessed 24 Jul 2023.</Citation></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22:e102&#x2013;e107. doi: 10.1016/S1473-3099(21)00703-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Selvakumar J, Havdal LB, Drevvatne M, Brodwall EM, Lund Berven L, Stiansen-Sonerud T, et al. Prevalence and characteristics associated with post-COVID-19 Condition among nonhospitalized adolescents and young adults. JAMA Netw Open. 2023;6:E235763. doi: 10.1001/jamanetworkopen.2023.5763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2023.5763</ArticleId><ArticleId IdType="pmc">PMC10064252</ArticleId><ArticleId IdType="pubmed">36995712</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28:657&#x2013;666. doi: 10.1016/j.cmi.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226:1593&#x2013;1607. doi: 10.1093/infdis/jiac136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac136</ArticleId><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:1&#x2013;12. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Mahoney LL, Routen A, Gillies C, Ekezie W, Welford A, Zhang A, et al. The prevalence and long-term health effects of long Covid among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. eClinicalMedicine. 2023;55:101762. doi: 10.1016/j.eclinm.2022.101762.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101762</ArticleId><ArticleId IdType="pmc">PMC9714474</ArticleId><ArticleId IdType="pubmed">36474804</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin-Chowdhury Z, Ladhani SN. Causation or confounding: why controls are critical for characterizing long COVID. Nat Med. 2021;27:1129&#x2013;1130. doi: 10.1038/s41591-021-01402-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01402-w</ArticleId><ArticleId IdType="pubmed">34140704</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng YB, Zeng N, Yuan K, Tian SS, Yang YB, Gao N, et al. Prevalence and risk factor for long COVID in children and adolescents: a meta-analysis and systematic review. J Infect Public Health. 2023;16:660&#x2013;672. doi: 10.1016/j.jiph.2023.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2023.03.005</ArticleId><ArticleId IdType="pmc">PMC9990879</ArticleId><ArticleId IdType="pubmed">36931142</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk factors associated with post-COVID-19 Condition a systematic review and meta-analysis. JAMA Intern Med. 2023;183:566&#x2013;580. doi: 10.1001/jamainternmed.2023.0750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamainternmed.2023.0750</ArticleId><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>Cochrane. 10.4.3.1 Recommendations on testing for funnel plot asymmetry. Database. 2008; Deeks 2005:2006&#x2013;7. https://handbook-5-1.cochrane.org/chapter_10/10_4_3_1_recommendations_on_testing_for_funnel_plot_asymmetry.htm. Accessed 24 Jul 2023.</Citation></Reference><Reference><Citation>Blankenburg J, Wekenborg MK, Reichert J, Kirsten C, Kahre E, Haag L, et al. Comparison of mental health outcomes in seropositive and seronegative adolescents during the COVID19 pandemic. Sci Rep. 2022;12:1&#x2013;8. doi: 10.1038/s41598-022-06166-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-06166-y</ArticleId><ArticleId IdType="pmc">PMC8831534</ArticleId><ArticleId IdType="pubmed">35145161</ArticleId></ArticleIdList></Reference><Reference><Citation>Boscolo-Rizzo P, Hummel T, Hopkins C, Dibattista M, Menini A, Spinato G, et al. High prevalence of long-term olfactory, gustatory, and chemesthesis dysfunction in post-covid-19 patients: a matched case-control study with 1-year follow-up using a comprehensive psychophysical evaluation. Rhinology. 2021;59:517&#x2013;527.</Citation><ArticleIdList><ArticleId IdType="pubmed">34553706</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro VM, Rosand J, Giacino JT, McCoy TH, Perlis RH. Case-control study of neuropsychiatric symptoms in electronic health records following COVID-19 hospitalization in 2 academic health systems. Mol Psychiatry. 2022;27:3898&#x2013;3903. doi: 10.1038/s41380-022-01646-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01646-z</ArticleId><ArticleId IdType="pmc">PMC9199464</ArticleId><ArticleId IdType="pubmed">35705635</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkan M, Dvir A, Zaidenstein R, Keller M, Kagansky D, Hochman C, et al. Patient-reported outcome measures after hospitalization during the covid-19 pandemic: a survey among covid-19 and non-covid-19 patients. Int J Gen Med. 2021;14:4829&#x2013;4836. doi: 10.2147/IJGM.S323316.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S323316</ArticleId><ArticleId IdType="pmc">PMC8405220</ArticleId><ArticleId IdType="pubmed">34471377</ArticleId></ArticleIdList></Reference><Reference><Citation>Fjelltveit EB, Blomberg B, Kuwelker K, Zhou F, Onyango TB, Brokstad KA, et al. Symptom burden and immune dynamics 6&#x2013;18 months following mild severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2): a case-control study. Clin Infect Dis. 2023;76:E60&#x2013;70. doi: 10.1093/cid/ciac655.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac655</ArticleId><ArticleId IdType="pmc">PMC9384725</ArticleId><ArticleId IdType="pubmed">35959897</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorecka M, Jex N, Thirunavukarasu S, Chowdhary A, Corrado J, Davison J, et al. Cardiovascular magnetic resonance imaging and spectroscopy in clinical long-COVID-19 syndrome: a prospective case&#x2013;control study. J Cardiovasc Magn Reson. 2022;24:1&#x2013;11. doi: 10.1186/s12968-022-00887-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-022-00887-9</ArticleId><ArticleId IdType="pmc">PMC9464490</ArticleId><ArticleId IdType="pubmed">36089591</ArticleId></ArticleIdList></Reference><Reference><Citation>Joy G, Artico J, Kurdi H, Seraphim A, Lau C, Thornton GD, et al. Prospective case-control study of cardiovascular abnormalities 6 months following mild COVID-19 in healthcare workers. JACC Cardiovasc Imaging. 2021;14:2155&#x2013;2166. doi: 10.1016/j.jcmg.2021.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2021.04.011</ArticleId><ArticleId IdType="pmc">PMC8105493</ArticleId><ArticleId IdType="pubmed">33975819</ArticleId></ArticleIdList></Reference><Reference><Citation>Liptak P, Duricek M, Rosolanka R, Ziacikova I, Kocan I, Uhrik P, et al. Gastrointestinal sequalae months after severe acute respiratory syndrome corona virus 2 infection: a prospective, observational study. Eur J Gastroenterol Hepatol. 2022;34:925&#x2013;932. doi: 10.1097/MEG.0000000000002425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MEG.0000000000002425</ArticleId><ArticleId IdType="pubmed">35913778</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B, Sudry T, Flaks-Manov N, Yehezkelli Y, Kalkstein N, Akiva P, et al. Long covid outcomes at 1 year after mild SARS-CoV-2 infection: nationwide cohort study. BMJ. 2023 doi: 10.1136/bmj-2022-072529.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-072529</ArticleId><ArticleId IdType="pmc">PMC9832503</ArticleId><ArticleId IdType="pubmed">36631153</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersesjan V, Fonsmark L, Christensen RHB, Amiri M, Merie C, Lebech AM, et al. Neuropsychiatric and cognitive outcomes in patients 6 months after COVID-19 requiring hospitalization compared with matched control patients hospitalized for non-COVID-19 illness. JAMA Psychiat. 2022;79:486&#x2013;497. doi: 10.1001/jamapsychiatry.2022.0284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamapsychiatry.2022.0284</ArticleId><ArticleId IdType="pmc">PMC8943626</ArticleId><ArticleId IdType="pubmed">35319743</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinto Pereira SM, Nugawela MD, Rojas NK, Shafran R, McOwat K, Simmons R, et al. Post-COVID-19 condition at 6 months and COVID-19 vaccination in non-hospitalised children and young people. Arch Dis Child. 2023;108:289&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10086284</ArticleId><ArticleId IdType="pubmed">36599625</ArticleId></ArticleIdList></Reference><Reference><Citation>Radtke T, Ulyte A, Puhan MA, Kriemler S. Long-term symptoms after SARS-CoV-2 infection in children and adolescents. JAMA: J Am Med Assoc. 2021;326:869&#x2013;871. doi: 10.1001/jama.2021.11880.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.11880</ArticleId><ArticleId IdType="pmc">PMC8283661</ArticleId><ArticleId IdType="pubmed">34264266</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivera-Izquierdo M, L&#xe1;inez-Ramos-Bossini AJ, de Alba IGF, Ortiz-Gonz&#xe1;lez-Serna R, Serrano-Ortiz &#xc1;, Fern&#xe1;ndez-Mart&#xed;nez NF, et al. Long COVID 12 months after discharge: persistent symptoms in patients hospitalised due to COVID-19 and patients hospitalised due to other causes: a multicentre cohort study. BMC Med. 2022;20:1&#x2013;10. doi: 10.1186/s12916-022-02292-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-022-02292-6</ArticleId><ArticleId IdType="pmc">PMC8863509</ArticleId><ArticleId IdType="pubmed">35193574</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;raas A, Kalleberg KT, Dahl JA, S&#xf8;raas CL, Myklebust T&#xc5;, Axelsen E, et al. Persisting symptoms three to 8 months after non-hospitalized COVID-19, a prospective cohort study. PLoS ONE. 2021;16(8):e0256142. doi: 10.1371/journal.pone.0256142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0256142</ArticleId><ArticleId IdType="pmc">PMC8389372</ArticleId><ArticleId IdType="pubmed">34437579</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson T, Pinto Pereira SM, Shafran R, de Stavola BL, Rojas N, McOwat K, et al. Physical and mental health 3 months after SARS-CoV-2 infection (long COVID) among adolescents in England (CLoCk): a national matched cohort study. Lancet Child Adolesc Heal. 2022;6:230&#x2013;239. doi: 10.1016/S2352-4642(22)00022-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-4642(22)00022-0</ArticleId><ArticleId IdType="pmc">PMC8820961</ArticleId><ArticleId IdType="pubmed">35143770</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarazona V, Kirouchena D, Clerc P, Pinsard-Laventure F, Bourrion B. Quality of life in COVID-19 outpatients: a long-term follow-up study. J Clin Med. 2022;11:6478. doi: 10.3390/jcm11216478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11216478</ArticleId><ArticleId IdType="pmc">PMC9657247</ArticleId><ArticleId IdType="pubmed">36362706</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Maaden T, Mutubuki EN, de Bruijn S, Leung KY, Knoop H, Slootweg J, et al. Prevalence and severity of symptoms 3 months after infection with SARS-CoV-2 compared to test-negative and population controls in the Netherlands. J Infect Dis. 2023;227:1059&#x2013;1067. doi: 10.1093/infdis/jiac474.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac474</ArticleId><ArticleId IdType="pubmed">36477364</ArticleId></ArticleIdList></Reference><Reference><Citation>Funk AL, Kuppermann N, Florin TA, Tancredi DJ, Xie J, Kim K, et al. Post-COVID-19 conditions among children 90 days after SARS-CoV-2 infection. JAMA Netw Open. 2022;5:E2223253. doi: 10.1001/jamanetworkopen.2022.23253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.23253</ArticleId><ArticleId IdType="pmc">PMC9308058</ArticleId><ArticleId IdType="pubmed">35867061</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson SB, von Feilitzen GS, Andersson ME, Sikora P, Lindh M, Nord&#xe9;n R, et al. Self-reported symptom severity, general health, and impairment in post-acute phases of COVID-19: retrospective cohort study of Swedish public employees. Sci Rep. 2022;12:1&#x2013;12. doi: 10.1038/s41598-022-24307-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-24307-1</ArticleId><ArticleId IdType="pmc">PMC9672032</ArticleId><ArticleId IdType="pubmed">36396860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, del Ayuzo Valle NC, Perelman C, Sepulveda R, Rebolledo PA, et al. Long-COVID in children and adolescents: a systematic review and meta-analyses. Sci Rep. 2022;12:9950. doi: 10.1038/s41598-022-13495-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-13495-5</ArticleId><ArticleId IdType="pmc">PMC9226045</ArticleId><ArticleId IdType="pubmed">35739136</ArticleId></ArticleIdList></Reference><Reference><Citation>Welge-L&#xfc;ssen A, Wolfensberger M. Olfactory disorders following upper respiratory tract infections. Adv Otorhinolaryngol. 2006;63:125&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pubmed">16733337</ArticleId></ArticleIdList></Reference><Reference><Citation>Stankevice D, Fjaeldstad AW, Agergaard J, Ovesen T. Long-term COVID-19 smell and taste disorders differ significantly from other post-infectious cases. Laryngoscope. 2023;133:169&#x2013;174. doi: 10.1002/lary.30453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/lary.30453</ArticleId><ArticleId IdType="pmc">PMC9874579</ArticleId><ArticleId IdType="pubmed">36305529</ArticleId></ArticleIdList></Reference><Reference><Citation>Neo JE, Tan BJW, Tan EK. &#x201c;Brain fog&#x201d; and COVID-19. Am J Med Sci. 2023;365(5):472&#x2013;474. doi: 10.1016/j.amjms.2023.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2023.01.003</ArticleId><ArticleId IdType="pmc">PMC9827745</ArticleId><ArticleId IdType="pubmed">36632867</ArticleId></ArticleIdList></Reference><Reference><Citation>Symptoms of COVID-19|CDC. https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html. Accessed 25 Jul 2023.</Citation></Reference><Reference><Citation>Islam MF, Cotler J, Jason LA. Post-viral fatigue and COVID-19: lessons from past epidemics. Fatigue Biomed Heal Behav. 2020;8:61&#x2013;69. doi: 10.1080/21641846.2020.1778227.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2020.1778227</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth KJ, Scheibenbogen C. Dyspnea in post-COVID syndrome following mild acute COVID-19 infections: potential causes and consequences for a therapeutic approach. Medicina (B Aires) 2022;58:419. doi: 10.3390/medicina58030419.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina58030419</ArticleId><ArticleId IdType="pmc">PMC8951558</ArticleId><ArticleId IdType="pubmed">35334595</ArticleId></ArticleIdList></Reference><Reference><Citation>Taverne J, Salvator H, Leboulch C, Barizien N, Ballester M, Imhaus E, et al. High incidence of hyperventilation syndrome after COVID-19. J Thorac Dis. 2021;13:3918. doi: 10.21037/jtd-20-2753.</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jtd-20-2753</ArticleId><ArticleId IdType="pmc">PMC8264705</ArticleId><ArticleId IdType="pubmed">34277081</ArticleId></ArticleIdList></Reference><Reference><Citation>Aparisi &#xc1;, Ybarra-falc&#xf3;n C, Garc&#xed;a-g&#xf3;mez M, Tobar J, Iglesias-echeverr&#xed;a C, Jaurrieta-largo S, et al. Exercise ventilatory inefficiency in post-covid-19 syndrome: Insights from a prospective evaluation. J Clin Med. 2021;10:2591. doi: 10.3390/jcm10122591.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10122591</ArticleId><ArticleId IdType="pmc">PMC8230788</ArticleId><ArticleId IdType="pubmed">34208271</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancini DM, Brunjes DL, Lala A, Trivieri MG, Contreras JP, Natelson BH. Use of cardiopulmonary stress testing for patients with unexplained dyspnea post-coronavirus disease. JACC Heart Fail. 2021;9:927. doi: 10.1016/j.jchf.2021.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jchf.2021.10.002</ArticleId><ArticleId IdType="pmc">PMC8629098</ArticleId><ArticleId IdType="pubmed">34857177</ArticleId></ArticleIdList></Reference><Reference><Citation>Motiejunaite J, Balagny P, Arnoult F, Mangin L, Bancal C, d&#x2019;Ortho MP, et al. Hyperventilation: a possible explanation for long-lasting exercise intolerance in mild COVID-19 survivors? Front Physiol. 2020;11:1856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7849606</ArticleId><ArticleId IdType="pubmed">33536937</ArticleId></ArticleIdList></Reference><Reference><Citation>Krumholz HM. Post-hospital syndrome: A condition of generalized risk. N Engl J Med. 2013;368:100. doi: 10.1056/NEJMp1212324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMp1212324</ArticleId><ArticleId IdType="pmc">PMC3688067</ArticleId><ArticleId IdType="pubmed">23301730</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawal G, Yadav S, Kumar R. Post-intensive care syndrome: an overview. J Transl Intern Med. 2017;5:90. doi: 10.1515/jtim-2016-0016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jtim-2016-0016</ArticleId><ArticleId IdType="pmc">PMC5506407</ArticleId><ArticleId IdType="pubmed">28721340</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn KL, Stukel TA, Huang A, Abdel-Qadir H, Altaf A, Bell CM, et al. Comparison of Medical and mental health sequelae following hospitalization for COVID-19, influenza, and sepsis. JAMA Intern Med. 2023 doi: 10.1001/JAMAINTERNMED.2023.2228.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/JAMAINTERNMED.2023.2228</ArticleId><ArticleId IdType="pmc">PMC10282961</ArticleId><ArticleId IdType="pubmed">37338892</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf8;nkj&#xe6;r CS, Christensen RHB, Kondziella D, Benros ME. Long-term neurological outcome after COVID-19 using all SARS-CoV-2 test results and hospitalisations in Denmark with 22-month follow-up. Nat Commun. 2023;14:1&#x2013;10. doi: 10.1038/s41467-023-39973-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-39973-6</ArticleId><ArticleId IdType="pmc">PMC10349860</ArticleId><ArticleId IdType="pubmed">37454151</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>